SREBF1 and fatty liver disease: Both SREBP-1 mRNA and its active nuclear protein are increased in ob/ob mouse livers; in double mutant Lepob/ob × Srebp-1−/− mice, hepatic steatosis was markedly attenuated, but obesity and insulin resistance remained persistent [42].